Grail

Grail Debt

The Debt of Grail (GRAL) as of Oct 20, 2026 is 11.72 M USD.

Debt

11.72 MUSD

Last updated:

In 2025, Grail's total debt was 11.72 M USD, a % change from the 0.00 USD total debt recorded in the previous year.

The Grail Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2018
1.73 M USD
Jan 1, 2019
0.00 USD
Jan 1, 2020
5.45 M USD
Jan 1, 2021
13.81 M USD
Jan 1, 2022
13.34 M USD
Jan 1, 2023
0.00 USD
Jan 1, 2024
0.00 USD
Jan 1, 2025
11.72 M USD
The Grail Debt history
YEARDebtYoY
11.72 MUSD—
0.00USD—
0.00USD-100.00%
13.34 MUSD-3.43%
13.81 MUSD+153.42%
5.45 MUSD—
0.00USD-100.00%
1.73 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Grail Stock analysis

What does Grail do? Grail Inc generates revenue through its Galleri and Beyond products, which are designed for multi-cancer early detection. Galleri is a commercially available screening test that identifies multiple cancer types in early stages using methylation-based technology, supporting healthcare providers in guiding diagnostic pathways. The company targets healthcare systems, hospitals, and insurance providers as key buyers, focusing on population-scale clinical studies and precision oncology applications. Its platform integrates next-generation sequencing, machine learning, and automation to address cancer detection across various care continuum segments. The business model centers on selling Galleri tests to healthcare institutions for use in patient screening programs, with Beyond serving as an additional product for precision oncology needs. Buyers include healthcare systems seeking to implement early cancer detection protocols and insurance companies aiming to reduce long-term treatment costs through early intervention. The company leverages its methylation-based platform to provide solutions for risk stratification, minimal residual disease detection, and treatment monitoring, aligning with the growing demand for advanced cancer screening technologies. Grail Inc's revenue streams are derived from the commercialization of Galleri, which is positioned as a multi-cancer early detection (MCED) tool, and Beyond, which supports specialized oncology applications. The company's target segments encompass healthcare providers, insurance partners, and research institutions involved in population-scale studies. By focusing on early detection and precision oncology, Grail Inc addresses unmet needs in cancer care through its technology-driven approach. Grail is one of the most popular companies on Eulerpool.

Debt Details

Understanding Grail's Debt Structure

Grail's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Grail's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Grail’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Grail’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Grail stock

Debt of Grail is 11.72 M USD in 2025.

On Eulerpool you can find the complete historical development of Debt Grail since 2006 – with annual values, charts, and detailed analysis.

Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Grail historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Grail

All Key Metrics — Grail